+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Genentech, Inc.  - logo

Genentech, Inc., a biotechnology company, engages in the research, development, manufacture, and marketing of biotechnology products for treating patients with serious or life-threatening diseases in the United States. It offers molecular entities and medicines in the areas of oncology, immunology, neuroscience, metabolism, and infectious diseases. The company was founded in 1976 and is headquartered in South San Francisco, California. Genentech operates as a subsidiary of Roche Holdings, Inc.

DNA Repair Drugs Market Report 2026 - Product Thumbnail Image

DNA Repair Drugs Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
RNA Targeting Small Molecules Therapeutics Market Report 2026 - Product Thumbnail Image

RNA Targeting Small Molecules Therapeutics Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Transforming Growth Factor Beta Inhibitors - Pipeline Insight, 2025 - Product Thumbnail Image

Transforming Growth Factor Beta Inhibitors - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 150 Pages
  • Global
From
Cervical Cancer Treatment - Global Strategic Business Report - Product Thumbnail Image

Cervical Cancer Treatment - Global Strategic Business Report

  • Report
  • June 2026
  • 372 Pages
  • Global
From
From
From
From
Gastrointestinal Collaboration and Licensing Deals 2016-2026 - Product Thumbnail Image

Gastrointestinal Collaboration and Licensing Deals 2016-2026

  • Report
  • April 2026
  • 200 Pages
  • Global
From
Immuno-oncology Market - Product Thumbnail Image

Immuno-oncology Market

  • Report
  • January 2024
  • 200 Pages
  • Global
From
Bacteraemia - Pipeline Insight, 2025 - Product Thumbnail Image

Bacteraemia - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 40 Pages
  • Global
From
Alpha 4 Beta 7 (A4b7) Integrin Inhibitor- - Pipeline Insight, 2025 - Product Thumbnail Image

Alpha 4 Beta 7 (A4b7) Integrin Inhibitor- - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Loading Indicator